Home › Funds › Prosight Management, LP › IMRX
Prosight Management, LP position in IMRX
IMMUNEERING CORP · Health Care
Prosight Management, LP reported holding 150,000 shares of IMRX (IMMUNEERING CORP) in its Q3 2026 13F filing — a position valued at US$614K, representing 0.12% of its reported portfolio and ranking #31 among its reported holdings. Prosight Management, LP has disclosed IMRX holdings in 5 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Prosight Management, LP's IMRX position evolved
Prosight Management, LP first disclosed a stake in IMRX in Q2 2024 at 550,000 shares (US$704K). Across 5 filings, Prosight Management, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 150,000 shares valued at US$614K — an increase of 113,139 shares quarter over quarter.. Notable position changes include a 65% trim in Q3 2024 (shares fell 12% over the following quarter), a 70% trim in Q2 2026 (shares fell 18% over the following quarter), a 307% increase in Q3 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 550.00K | $704.00K | New |
| Q3 2024 | 190.00K | $473.10K | Reduce |
| Q1 2026 | 123.41K | $650.37K | New |
| Q2 2026 | 36.86K | $183.94K | Reduce |
| Q3 2026 | 150.00K | $614.25K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMRX and 13F data
IMRX (IMMUNEERING CORP) is a Health Care company. 50 other funds we track also report a position in IMRX — the largest reported positions include Sanofi (US$11.1M), DCF Advisers, LLC (US$3.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMRX
- Sanofi 2.71M sh · $11.09M · Q3 2026
- DCF Advisers, LLC 862.50K sh · $3.53M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 472.94K sh · $1.94M · Q3 2026
- Occam Crest Management LP 324.70K sh · $1.33M · Q3 2026
More on Prosight Management, LP
FAQ
How long has Prosight Management, LP held IMRX?
Prosight Management, LP has disclosed IMRX holdings in 5 of the last 10 reported quarters, going back to Q2 2024.
What is Prosight Management, LP's current position in IMRX?
As of Q3 2026, Prosight Management, LP holds 150.00K shares of IMRX (IMMUNEERING CORP), valued at $614.25K, representing 0.12% of its reported portfolio and ranking #31.
Has Prosight Management, LP been buying or selling IMRX?
In the latest 13F filing (Q3 2026), Prosight Management, LP increased its position in IMRX.
Which other funds hold IMRX?
Other major institutional holders of IMRX include Sanofi, DCF Advisers, LLC, ALETHEA CAPITAL MANAGEMENT, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.